Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Invasive aspergillosis: a study of 20 cases].

M Rivero Marcotegui1, L Torroba Alvarez, E Urbiola Mascilla

  • 1Servicio de Medicina Interna, Hospital Virgen del Camino, Pamplona.

Revista Clinica Espanola
|March 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aortic dissection class 3: a little-known entity. Presentation of 4 cases.

Radiologia·2019
Same author

[Late diagnosis of HIV infection: missed diagnostic opportunities].

Anales del sistema sanitario de Navarra·2015
Same author

[Kingella kingae endocarditis].

Anales de pediatria (Barcelona, Spain : 2003)·2011
Same author

[Vertebral osteomyelitis caused by Streptococcus agalactiae in healthy adults. Description of 2 new cases].

Revista clinica espanola·2009
Same author

Cardiac conotruncal malformations in a family of beagle dogs.

The Journal of small animal practice·2009
Same author

[Lemierre's syndrome and Mycoplasma pneumoniae].

Anales de medicina interna (Madrid, Spain : 1984)·2006

Invasive aspergillosis (IA) affects more patients without severe immunosuppression than expected. Early diagnosis and antifungal therapy are crucial for improving survival rates in IA cases.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Epidemiology

Context:

  • Invasive aspergillosis (IA) is a serious fungal infection.
  • Accurate diagnosis and timely treatment are critical for patient outcomes.
  • Understanding the epidemiology of IA aids in clinical recognition and management.

Purpose:

  • To evaluate the epidemiology of invasive aspergillosis (IA).
  • To determine the frequency of IA recognition in clinical practice.
  • To analyze patient characteristics and outcomes associated with IA.

Summary:

  • A retrospective analysis identified 20 IA cases over three years.
  • Nearly half of patients had hematologic malignancy, and many received corticosteroids.
  • A significant proportion (15%) had no clear immunosuppression risk factors.

Related Experiment Videos

  • IA was suspected in 75% of cases, with sputum culture showing high sensitivity.
  • Mortality was high (85%), often despite antifungal treatment, with a median delay of 14 days from symptoms to therapy.

    • Impact:

    • The study highlights that IA occurs in patients without typical risk factors like neutropenia.
    • IA diagnosis remains challenging, sometimes requiring post-mortem confirmation.
    • Early initiation of antifungal therapy is essential for better prognosis.
    • A high index of suspicion for IA is necessary in both immunocompromised and immunocompetent patients.